Karuna Therapeutics, Inc. KRTX
Set alert
At close · Mar 15
52-week range unavailable
- Open
- 329.75
- Prev close
- 329.83
- Mkt cap
- 12.60B
- Vol
- 1.28M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 329.75
- High
- 329.97
- Forward P/E
- -36.49
- Beta
- 1.15
- Short ratio
- 3.60
- Inst. own
- 86.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 2, 2024
- 50-d avg
- 317.71
- 200-d avg
- 230.08
- 1y target
- 324.17
Discussion (11)
Sign in to join the discussion
Offering appears to be taking 2.6MM shares divided by current 23.4MM shares for an 89% rate multiplied by closing price of 108.95 calculates to $96 a share. There is an additional option of another 390,000 shares though so the price should be a little lower then $96 a share if you feel this is the true value of the company.
$KRTX going to sub $100 a fair value 65 to 80
$KRTX As a trader and a psychologist who has a son living with schizophrenia I could not not buy. You can not imagine what this new medication could bring. If it does what they assert, it will frankly be a revolution in the field of mental health . It could completely change the sick peoples live and the life of their family members. Hope.
SHOT SHOT SHOT.. TOMORROW GET PROFITS
Operating income is -$15M .. The. COmpany take money$$$$from investors today.
Tomorrow back to$40!
Phase III still far away ...unknown yet
Tomorrow back$40
Best time to short now